Evidence map›Paper›PMID 39741063›Full record

SynthesisInternational dental journal2025

Bioengineering Innovations in Global Dental Infection Control: Applications and Adaptations in Clinical Settings.

Abdullah Khalid Amer AlSaiari, Mohammad S Alonazi, Nasser Muneer Alotaibi, Hamad AlQahtani, Waleed Masoud Alotaibi, Awatef Sliman Saleh Al Yhyha, Aqilah Aldarorah, Nawal Megad Alaklabi, Thuraya Ahmed Saleh Al-Obayli, Ohoud Abdulhadi Salha Alsaud and 2 more

Abstract readSystematic Review
In one paragraph

Synthesis in International dental journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Abdullah Khalid Amer AlSaiariKing Salman Hospital, Ministry of Health, Riyadh, Saudi Arabia. Electronic address: akalsaiari@moh.gov.sa.
Mohammad S AlonaziKing Salman Hospital, Ministry of Health, Riyadh, Saudi Arabia.
Nasser Muneer AlotaibiKing Salman Hospital, Ministry of Health, Riyadh, Saudi Arabia.
Hamad AlQahtaniKing Salman Hospital, Ministry of Health, Riyadh, Saudi Arabia.
Waleed Masoud AlotaibiKing Salman Hospital, Ministry of Health, Riyadh, Saudi Arabia.
Awatef Sliman Saleh Al YhyhaKing Salman Hospital, Ministry of Health, Riyadh, Saudi Arabia.
Aqilah AldarorahKing Salman Hospital, Ministry of Health, Riyadh, Saudi Arabia.
Nawal Megad AlaklabiKing Salman Hospital, Ministry of Health, Riyadh, Saudi Arabia.
Thuraya Ahmed Saleh Al-ObayliKing Salman Hospital, Ministry of Health, Riyadh, Saudi Arabia.
Ohoud Abdulhadi Salha AlsaudKing Salman Hospital, Ministry of Health, Riyadh, Saudi Arabia.
Latifa Abdulrahman AlosaimiKing Salman Hospital, Ministry of Health, Riyadh, Saudi Arabia.
Manal Ghazi Al BeshiKing Salman Hospital, Ministry of Health, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

INTRODUCTION AND

aimsDental practices pose a high risk of microbial contamination due to frequent exposure to bodily fluids like saliva and blood. Bioengineering innovations have emerged as vital tools to enhance infection control in dental settings. This review aims to assess the global applications and effectiveness of these innovations, particularly focusing on antimicrobial biomaterials, sterilization techniques, and personal protective equipment (PPE).

methodsA systematic review was conducted across major databases to identify studies from 2000 to 2024 that examined bioengineering technologies used in dental infection control. Inclusion criteria included studies focusing on antimicrobial materials, PPE, or novel sterilization technologies. Data extraction followed PRISMA guidelines, focusing on study design, dental settings, and clinical outcomes related to infection control.

resultsNine studies met the inclusion criteria, covering diverse geographical regions, including Italy, Saudi Arabia, Brazil, and India. Antimicrobial agents like silver and zinc oxide nanoparticles, UV-C sterilization, and low-temperature plasma were found to significantly reduce microbial contamination. The pooled effect size across studies was 1.62 (95% CI: 1.41-1.82) with low heterogeneity (I² = 6.4%). However, barriers such as high costs and limited resource availability were highlighted, particularly in lower-income regions.

conclusionBioengineering innovations show significant potential for enhancing infection control in dental settings worldwide. While the technologies offer improved safety and hygiene, challenges related to cost and accessibility persist. Further research is needed to explore cost-effective and scalable solutions, particularly in resource-limited settings. CLINICAL RELEVANCE: The integration of bioengineering technologies in dental practices can significantly improve infection control measures, reducing microbial contamination and enhancing safety for both patients and healthcare workers. These innovations hold promise for global adaptation, particularly in response to emerging public health challenges.

Indexed as

BioengineeringInfection Control, DentalAnti-Infective AgentsGlobal HealthHumansSterilizationAnti-Infective AgentsAntimicrobial BiomaterialsBioengineering InnovationsDental Infection ControlPersonal Protective EquipmentSterilization Technologies

Identifiers

PMID39741063
PMCPMC12142762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.